ES2620740T3 - Epítopos de células T CD4 de PAP promiscuos - Google Patents

Epítopos de células T CD4 de PAP promiscuos Download PDF

Info

Publication number
ES2620740T3
ES2620740T3 ES07840861.4T ES07840861T ES2620740T3 ES 2620740 T3 ES2620740 T3 ES 2620740T3 ES 07840861 T ES07840861 T ES 07840861T ES 2620740 T3 ES2620740 T3 ES 2620740T3
Authority
ES
Spain
Prior art keywords
presenting cells
antigen presenting
expressing antigen
cell epitopes
expressing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES07840861.4T
Other languages
English (en)
Spanish (es)
Inventor
Jami B. Wollan
Lori A. Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dendreon Pharmaceuticals LLC
Original Assignee
Dendreon Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dendreon Pharmaceuticals LLC filed Critical Dendreon Pharmaceuticals LLC
Application granted granted Critical
Publication of ES2620740T3 publication Critical patent/ES2620740T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES07840861.4T 2006-08-11 2007-08-10 Epítopos de células T CD4 de PAP promiscuos Active ES2620740T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US83705306P 2006-08-11 2006-08-11
US837053P 2006-08-11
US836653 2007-08-09
US11/836,653 US8361479B2 (en) 2006-08-11 2007-08-09 Promiscuous PAP CD4 T cell epitopes
PCT/US2007/075704 WO2008022030A2 (en) 2006-08-11 2007-08-10 Promiscuous pap cd4 t cell epitopes

Publications (1)

Publication Number Publication Date
ES2620740T3 true ES2620740T3 (es) 2017-06-29

Family

ID=39082999

Family Applications (1)

Application Number Title Priority Date Filing Date
ES07840861.4T Active ES2620740T3 (es) 2006-08-11 2007-08-10 Epítopos de células T CD4 de PAP promiscuos

Country Status (7)

Country Link
US (2) US8361479B2 (https=)
EP (1) EP2056859B1 (https=)
JP (1) JP5189094B2 (https=)
CA (1) CA2660064C (https=)
ES (1) ES2620740T3 (https=)
PL (1) PL2056859T3 (https=)
WO (1) WO2008022030A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2376923A4 (en) * 2008-12-22 2012-08-15 Children S Res Inst METHOD FOR DETECTING SEPSIS
WO2010119307A1 (en) * 2009-04-14 2010-10-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for stimulating antigen-specific t cell responses using accelerated co-cultured dendritic cells
GB2484058A (en) * 2009-12-01 2012-04-04 Uni Konstanz Prostate cancer DNA vaccine
FR3000263B1 (fr) * 2012-12-21 2015-03-06 Ingenico Sa Detection d'un dispositif transactionnel
WO2017096247A1 (en) * 2015-12-04 2017-06-08 Mayo Foundation For Medical Education And Research Methods and vaccines for inducing immune responses to multiple different mhc molecules
CN110079539B (zh) * 2018-01-25 2022-07-01 上海惠盾因泰生物科技有限公司 前列腺酸性磷酸酶/粒-巨噬细胞集落刺激因子制备方法
IT202000013243A1 (it) 2020-06-04 2021-12-04 Novamont Spa Processo per la purificazione di una miscela di dioli

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552534A (en) 1991-08-22 1996-09-03 The Trustees Of The University Of Pennsylvania Non-Peptide peptidomimetics
US5550251A (en) 1991-12-12 1996-08-27 The Trustees Of The University Of Pennsylvania Alicyclic peptidomimetics
US6080409A (en) * 1995-12-28 2000-06-27 Dendreon Corporation Immunostimulatory method
CA2394741A1 (en) * 1999-12-21 2001-06-28 Epimmune Inc. Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions
CA2497554A1 (en) 2002-09-20 2004-04-01 Dendreon Corporation Immunotherapeutic compositions and methods for the treatment of moderately to well-differentiated cancers
CA2500715A1 (en) 2002-10-03 2004-04-15 Epimmune Inc. Hla binding peptides and their uses

Also Published As

Publication number Publication date
JP5189094B2 (ja) 2013-04-24
EP2056859B1 (en) 2017-01-11
US20130203163A1 (en) 2013-08-08
EP2056859A2 (en) 2009-05-13
US8361479B2 (en) 2013-01-29
US8647865B2 (en) 2014-02-11
WO2008022030A3 (en) 2008-11-27
PL2056859T3 (pl) 2017-07-31
WO2008022030A2 (en) 2008-02-21
JP2010500037A (ja) 2010-01-07
WO2008022030A9 (en) 2008-04-10
CA2660064A1 (en) 2008-02-21
US20080286293A1 (en) 2008-11-20
CA2660064C (en) 2016-08-09
EP2056859A4 (en) 2010-03-31

Similar Documents

Publication Publication Date Title
ES2620740T3 (es) Epítopos de células T CD4 de PAP promiscuos
ES2486675T3 (es) Análogo de péptido de oxintomodulina
ES2512141T3 (es) Análogo peptídico de oxintomodulina
ES2559062T3 (es) Método para la activación de linfocitos T colaboradores y composición para su uso en el método
ES2616658T3 (es) Péptidos que mimetizan el factor de crecimiento y sus usos
WO2005013666A3 (en) Novel translocation assay
Zou et al. Characterization of the effects of trace concentrations of graphene oxide on zebrafish larvae through proteomic and standard methods
NO20030856D0 (no) Membranpenetrerende peptider og anvendelse av disse
HRP20090245T1 (en) Pyy agonists and uses thereof
BRPI0506474A (pt) sistema de tecido com células tronco não diferenciadas derivadas no limbus da córnea
WO2005010215A3 (en) Methods for identifying tolerance modulatory compounds and uses therefor
AR081354A1 (es) Metodos y reactivos par una transferencia genica eficaz y dirigida a monocitos y macrofagos
Zhou et al. Primary cultured cells as sensitive in vitro model for assessment of toxicants-comparison to hepatocytes and gill epithelia
TWD203721S (zh) 絞車(二)
Held et al. Development of a metabolically stable neurotensin receptor 2 (NTS2) ligand
BRPI0518579A2 (pt) mÉtodo para aumentar a atividade de cÉlula exterminadora natural em um animal, kit adequado para alimentar Ácido lipàico a um animal, meio para comunicar informaÇço, composiÇço, uso da composiÇço que compreende Ácido lipàico, e, mÉtodo para aumentar a resposta imune em um animal
IL192484A0 (en) Luminescent transgenic non human animals, progeny, cell derivatives and uses thereof
WO2009107971A3 (ko) 포스파티딜세린과 특이적으로 결합하는 폴리펩티드 및 이의 용도
DE602007004110D1 (de) Hausstaubmilbenallergen
Hu et al. Surviving in an acidifying ocean: acid-base physiology and energetics of the sea urchin larva
Javitt et al. A novel alanine-insensitive D-serine transporter in rat brain synaptosomal membranes
MX2010010213A (es) Peptido parcial de lacritina.
Kaya et al. Spiroidesin, a novel lipopeptide from the cyanobacterium Anabaena spiroides that inhibits cell growth of the cyanobacterium Microcystis aeruginosa
NZ551828A (en) A method of cell isolating a homogenous population of mammary stem cells using specific cell surface marker proteins
Verdon et al. An in vitro model of infection of human biliary epithelial cells by Cryptosporidium parvum